Nuvectis Pharma, Inc.NVCTNASDAQ
Loading
Price-to-book ratio
3Y CAGR
+10.2%/yr
Annual compound
Percentile
P60
Within normal range
vs 3Y Ago
1.3x
Solid growth
Streak
2 yr
Consecutive declineElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 8.94 | -6.2% |
| 2024 | 9.53 | -10.4% |
| 2023 | 10.63 | +59.3% |
| 2022 | 6.68 | +277.8% |
| 2021 | -3.75 | +99.9% |
| 2020 | -4133.28 | - |